Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01254
Species: Homo sapiens
Position : chr8:130180000-130181000
Year: 2018
Title: ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: T-cell acute lymphoblastic leukemia
PMID:  29326336
MONDO: MONDO:0004947
Tissue: Blood
Tissue Ontology ID: UBERON:0000178
Cell Source: CCRF-CEM
CVCL ID: CVCL_0207
Cell Type: T lymphoblast
Cell Ontology ID: CL:0002419
Experiment Type: Enhancer activity assay, functional perturbation assay
High Throughput Method: ChIP-seq, ChIA-PET
Low Throughput Method: qRT-PCR, and ChIP-qPCR
About Target Gene
Target gene : MYC
About TF
TF name : ARID5B
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
ARID5B HDMs demethylate histones reactome 49
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_01253 chr8:130180000-130181000 Blood T lymphoblast T-cell acute lymphoblastic leukemia
E_00452 chr8:130180065-130180972 Blood T lymphoblast T-cell acute lymphoblastic leukemia
E_00325 chr8:130180217-130180629 Peripheral Blood T cell adult T-cell leukemia/lymphoma
Expression of Target Genes for the Enhancer